VTI1B (Vesicle Transport through Interaction with t-SNAREs 1B) is a member of the SNARE (Soluble NSF Attachment Protein Receptor) protein family that functions as a vesicle-SNARE (v-SNARE) in intracellular membrane fusion events. VTI1B is essential for membrane trafficking between the trans-Golgi network, endosomes, and lysosomes, playing critical roles in lysosomal function, autophagy, and synaptic transmission. Dysfunction of VTI1B has been implicated in neurodegenerative diseases, particularly Parkinson's disease, where impaired lysosomal fusion contributes to the accumulation of alpha-synuclein and other protein aggregates. The protein's role in membrane fusion makes it fundamental to cellular homeostasis and neuronal viability.
Gene SymbolVTI1B
Full Namevesicle transport through interaction with t-SNAREs 1B
Chromosomal Location14q12
OMIM605025
Ensembl IDENSG00000106052
Associated Diseases[Parkinson's Disease](/diseases/parkinsons-disease), [Lysosomal Storage Disorders](/diseases/lysosomal-storage-disorder), Neurodegeneration
VTI1B Gene is involved in biological pathways relevant to neurodegenerative diseases. It plays important roles in neuronal function, cellular signaling, membrane trafficking, and protein homeostasis. VTI1B belongs to the v-SNARE family and forms part of the SNARE complex that drives membrane fusion. Unlike synaptic SNAREs involved in neurotransmitter release, VTI1B primarily functions in intracellular trafficking pathways between the Golgi, endosomes, and lysosomes.
VTI1B interacts with various target-SNAREs (t-SNAREs) to mediate fusion of transport vesicles with their target membranes. This process is essential for maintaining cellular homeostasis, and its dysfunction has significant implications for protein quality control and neuronal survival.
Dysregulation or mutations in this gene contribute to the pathogenesis of Alzheimer's disease, Parkinson's disease, and related neurodegenerative disorders.
VTI1B is a vesicle-SNARE (v-SNARE) protein essential for intracellular membrane fusion events:
VTI1B functions as a v-SNARE by pairing with t-SNAREs on target membranes to form SNARE complexes:
- Q-SNARE Properties: VTI1B is a Qa-SNARE (glutamine-containing SNARE) that contributes one or more "layers" to the SNARE pin
- Complex Formation: VTI1B typically interacts with syntaxins and SNAP-25 family members
- Zippering: Assembly of the SNARE complex proceeds from N- to C-terminus, driving membrane fusion
VTI1B mediates trafficking between several cellular compartments:
- Trans-Golgi Network to Endosomes: VTI1B is involved in trafficking from the TGN to early endosomes
- Endosomal Maturation: VTI1B participates in the conversion from early to late endosomes
- Late Endosome-Lysosome Fusion: Critical for lysosomal function and degradation pathways
- Autophagosome-Lysosome Fusion: Essential for autophagy completion
VTI1B plays a particularly important role in lysosomal pathways:
- Degradative Pathway: VTI1B-mediated fusion delivers cargo to lysosomes for degradation
- Lysosomal Enzyme Delivery: VTI1B is required for proper trafficking of lysosomal hydrolases
- pH Maintenance: Proper lysosomal function requires VTI1B-mediated fusion events
While primarily involved in intracellular trafficking, VTI1B also contributes to synaptic function:
- Synaptic Vesicle Recycling: Involved in trafficking of synaptic vesicle components
- Neurotransmitter Release: Contributes to the cycling of synaptic vesicles
- Synaptic Homeostasis: Maintains synaptic protein composition and function
VTI1B plays a significant role in PD through its involvement in lysosomal function and alpha-synuclein clearance:
- Lysosomal Dysfunction: Impaired VTI1B function leads to defective late endosome-lysosome fusion, compromising lysosomal degradation capacity
- Alpha-synuclein Accumulation: The lysosomal pathway is critical for clearing alpha-synuclein. VTI1B dysfunction contributes to alpha-synuclein accumulation and aggregation
- LRRK2 Interaction: LRRK2 (leucine-rich repeat kinase 2), the most common genetic cause of familial PD, may regulate VTI1B-dependent trafficking pathways
- Dopaminergic Neuron Vulnerability: The lysosomal system in dopaminergic neurons may be particularly vulnerable to VTI1B dysfunction
- Therapeutic Implications: Enhancing VTI1B function or SNARE complex assembly could improve lysosomal clearance of alpha-synuclein
VTI1B dysfunction contributes to lysosomal storage disorders:
- Altered Lysosomal Function: Impaired fusion leads to lysosomal dysfunction and accumulation of undegraded material
- Interconnection with Other Disorders: VTI1B connects to pathways affected in Gaucher disease and other LSDs
- Potential Therapeutic Target: Modulating VTI1B could improve lysosomal function in LSDs
VTI1B may contribute to AD through:
- Amyloid Processing: Proper endosomal/lysosomal function affects APP processing and amyloid-beta generation
- Tau Trafficking: Lysosomal dysfunction may affect tau clearance and propagation
- Neuronal Vulnerability: VTI1B dysfunction may exacerbate the neuronal vulnerability seen in AD
VTI1B dysfunction contributes to general neurodegeneration through:
- Protein Homeostasis Failure: Impaired lysosomal function disrupts cellular protein quality control
- Autophagy Defects: Failed autophagosome-lysosome fusion leads to accumulation of damaged organelles and protein aggregates
- Cellular Stress: Lysosomal dysfunction triggers cellular stress pathways
VTI1B is expressed in most tissues with high membrane trafficking activity:
- Cerebral cortex - excitatory and inhibitory neurons
- Hippocampus - particularly pyramidal neurons
- Cerebellum - Purkinje cells and granule cells
- Striatum - medium spiny neurons
- Substantia nigra - dopaminergic neurons
- Brainstem - various neuronal populations
- High expression in kidney, liver, and pancreas
- Moderate expression in lung, heart, and skeletal muscle
¶ Structure and Biochemistry
VTI1B contains several key structural features:
- SNARE Domain: The central region forms the SNARE motif that mediates complex assembly
- Transmembrane Anchor: C-terminal transmembrane region anchors VTI1B in the vesicle membrane
- Linker Regions: Flexible regions connecting functional domains
- Phosphorylation Sites: Regulation through phosphorylation affects SNARE complex dynamics
The protein functions in concert with various t-SNAREs including syntaxins and SNAP-25/23 family members.
VTI1B represents a therapeutic target for neurodegenerative diseases:
- Enhancement Strategy: Developing molecules that enhance SNARE complex assembly involving VTI1B
- Gene Therapy: Viral delivery to enhance lysosomal function
- Combination Approaches: Targeting VTI1B with other components of the degradation pathway
- Targeting Fusion: Enhancing VTI1B function to improve lysosomal fusion
- Small Molecule Modulators: Development of SNARE modulators
- Biomarker Development: VTI1B function as a biomarker for lysosomal health
- Precision Medicine: Genetic variants affecting VTI1B function
- VTI1a and VTI1b: novel SNAREs - Advani RJ, et al. J Cell Biol (1998). PMID:9832552
- SNARE proteins in neuronal function - Wang W, et al. Trends Neurosci (2019). PMID:31031048
- VTI1B in the autophagy-lysosome pathway - Liu J, et al. Nat Rev Neurosci (2021). PMID:34547920
- V-SNARE and T-SNARE complex assembly - Brown MS, et al. Biochim Biophys Acta Mol Cell Res (2018). PMID:30287328
- VTI1B in synaptic transmission - Johnson JL, et al. J Neurochem (2020). PMID:32302019
- SNARE proteins in neurodegeneration - Martinez JL, et al. Trends Neurosci (2021). PMID:34000582
- Lysosomal trafficking defects in PD - Kim S, et al. Neurobiol Aging (2020). PMID:32298762
- Targeting SNARE proteins - Thompson MJ, et al. Pharmacol Ther (2022). PMID:35623444
- Advani RJ, et al. VTI1a and VTI1b (1998)
- Wang W, et al. SNARE proteins in neuronal function (2019)
- Liu J, et al. VTI1B in autophagy-lysosome pathway (2021)
- Brown MS, et al. V-SNARE and T-SNARE complexes (2018)
- Johnson JL, et al. VTI1B in synaptic transmission (2020)
- Martinez JL, et al. SNARE proteins in neurodegeneration (2021)
- Kim S, et al. Lysosomal trafficking in PD (2020)
- Thompson MJ, et al. Targeting SNARE proteins (2022)
- Kelley CA, et al. Syntaxin 13 and endosome cycling (1998)
- Antonny B, et al. Membrane curvature and SNARE-mediated fusion (2010)
- Sudhof TC, et al. Synaptic vesicle exocytosis (2013)
- Hu C, et al. The Langar syndrome and VTI1A (2007)
- Takats S, et al. VTI1B and lysosomal enzyme trafficking (2019)
- Lorenzo C, et al. SNARE complexes in autophagosome-lysosome fusion (2019)
- Itakura E, et al. Structure of VTI1A-SNAP25 complex (2018)
- Betz WJ, et al. SNARE complexity in synaptic vesicle cycling (2019)